Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
The scope of the present clinical study is to conduct research on biomarkers of clinical activity of SLE (Human IFN-gamma, Human IFN-alpha, Human sICAM-1, Human sVCAM-1, Human sIL-2R, and TNF-R) and to determine the connection between laboratory biomarkers and clinical and immunological activity of...
Saved in:
Main Authors: | Valentina Reshkova, Dobroslav Kyurkchiev, Simeon Monov |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2025-01-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/132051/download/pdf/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Off-label short-term use of thiocolchicoside (Tiyozid®) in the clinical therapy of fibromyalgia
by: Valentina Reshkova, et al.
Published: (2025-01-01) -
Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis
by: Jing Xue, et al.
Published: (2017-01-01) -
SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus
by: Chi-Hui Yang, et al.
Published: (2025-01-01) -
Peripheral Classic and Intermediate Monocyte Subsets as Immune Biomarkers of Systemic Lupus Erythematosus Disease Activity
by: Amaylia Oehadian, et al.
Published: (2024-10-01) -
Salivary Cytokines as Potential Diagnostic Biomarkers for Systemic Lupus Erythematosus Disease
by: Zeineb Zian, et al.
Published: (2021-01-01)